Jorge Marrero
Appearances
- DateMay 21, 2024BACKGROUND: With the recent increase in metabolic liver diseases and viral hepatitis on anti-viral agents, risk stratification biomarkers are urgently needed to identify cirrhosis patients who should be prioritized for hepatocellular carcinoma (HCC) screening for early detection…
Presenter
Speakers
University of MichiganMayo Foundation for Medical Education and ResearchBaylor College of MedicineBaylor University Medical CenterMichael E. DeBakey VAMCBaylor College of MedicineUT Southwestern Medical CenterUniversity of Texas Southwestern Medical Center - DateMay 21, 2024BACKGROUND. Several inflammatory and metabolic biomarkers have been associated with hepatocellular carcinoma (HCC) risk in phase I and II biomarker studies but not in longitudinal studies…
Presenter
Baylor College of MedicineSpeakers
Michael E. DeBakey VAMCBaylor College of MedicineUT Southwestern Medical CenterBaylor University Medical Center
